|
BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies |
||||
|---|---|---|---|---|
| Company |
Ticker
|
Current Price
(March 22, 2005) |
Last Price
(March 15, 2005) |
% Change
|
| Agilent |
A
|
22.58
|
23.26
|
-2.92
|
|
Applied Biosystems
|
ABI
|
20.36
|
20.34
|
0.10
|
| BD |
BDX
|
58.62
|
58.85
|
-0.39
|
| Beckman |
BEC
|
68.90
|
70.78
|
-2.66
|
| Bio-Rad |
BIO
|
48.00
|
47.83
|
0.36
|
| Bruker |
BRKR
|
3.26
|
3.95
|
-17.47
|
| GE |
GE
|
35.50
|
36.00
|
-1.39
|
| Harvard Bio |
HBIO
|
4.08
|
3.95
|
3.29
|
| Invitrogen |
IVGN
|
71.31
|
71.40
|
-0.13
|
| Molecular Devices |
MDCC
|
18.98
|
18.76
|
1.17
|
| PerkinElmer |
PKI
|
21.00
|
21.90
|
-4.11
|
| Sigma |
SIAL
|
62.07
|
63.00
|
-1.48
|
| Stratagene |
STGN
|
8.05
|
8.00
|
0.63
|
| Thermo |
TMO
|
25.33
|
27.45
|
-7.72
|
| Waters |
WAT
|
46.67
|
47.85
|
-2.47
|
| Index Average |
|
34.31
|
34.89
|
-1.65
|
Â
Bruker Shares Tumble After 10-K Filing Extension Request
Bruker shares lost 17 percent in the five-day period ending Tuesday and the BioCommerce Week Index finished down for a second consecutive week.
Bruker lost 17 percent of its market capitalization, or $61 million, after announcing last week that it would request an extension of the deadline for filing its 10-K report. The company said it would restate its net loss between $0.07 and $0.09 a share from its previously reported $0.06 a share after finding a "material weakness" in its internal controls at one of its subsidiaries.
Bruker's market cap was $291 million as of market close Tuesday.
Harvard Bio shares gained 3.3 percent on the week, ending a string of five straight weeks of losses, to lead five companies whose shares finished up. Seven companies' shares lost ground as Thermo Electron dropped 7.7 percent, PerkinElmer fell 4 percent, and Agilent dropped 3 percent.
Overall, the Index closed at $34.89 for the five-day period, down 1.65 percent from last week. The Index has closed down for two consecutive weeks and has been down for four of the last six weeks since reaching a high of $36.10 on Feb. 8.
For the week, the Index outperformed the S&P 500 and the Nasdaq, which fell 2 percent, and the Dow Jones, which dropped 2.3 percent. The Amex biotech index was down 0.5 percent while the Amex pharma index fell 1.7 percent.